Advances in Nutrition , 12(6), 25402552
Regular follow-up appointments, typically scheduled every 4 to 12 weeks during the initial treatment phase, allow for dose adjustments, side effect management, and monitoring of therapeutic outcomes
Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA 1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent
If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule
This custom program combines several treatments to help you get the best results
A pharmacy that tests ensures that the labeled dose actually matches what is in the vial